Boehringer Ingelheim: Clinical Trials & Research Profile

Biopharma Industry (Ingelheim, DE / Ridgefield, CT) · Primary Focus: Endocrinology, Obesity, and Metabolic

Clinical Trial MetricVerified Public Record
Organization TypeConsolidated Trial Sponsor
Institutional Sector & LocationBiopharma Industry (Ingelheim, DE / Ridgefield, CT)
Primary Therapeutic AreaEndocrinology, Obesity, and Metabolic
Active Phase II & III Studies45 active (28 recruiting now)
Total Tracked Studies (2018 to 2026)139 (94 with California sites)
Completed vs Early-Stopped Studies70 completed / 24 stopped (17.3% stop rate)
Median Closed Enrollment156 participants
FDA Drugs@FDA Original Approvals54 all-time (6 from 2018 to 2026)
Physical Hospital Site Disclosure99.9% named hospital slots

Related Filings Across Meru Platforms

Verified cross-ledger federal filings for Boehringer Ingelheim across sibling Meru public-data platforms.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI -> · AI for Healthcare · Healthcare Price & Patent Cliff Crosswalk